Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Amrif Logo
Amrif CB Rank
1170044
Heat Score
72
Amrif develops treatments for chronic inflammatory diseases and works on RESCAP for age-related diseases.
Founded
obfuscation
Private Wageningen, Gelderland, The Netherlands11-50 www.amrif.eu
Biotechnology
Clinical Trials
Health Care
Manufacturing
Overview

Amrif
Heat Score
72

Growth Score
pts
in past quarter
Heat Score 72
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Amrif

CB Rank
1170044
Amrif develops treatments for chronic inflammatory diseases and works on RESCAP for age-related diseases.
Founded
obfuscation
Private Wageningen, Gelderland, The Netherlands11-50 www.amrif.eu
Biotechnology
Clinical Trials
Health Care
Manufacturing

Details

Legal Name Amrif
Operating Status Active
Company Type For Profit
Phone Number +31 647228395
Contact Email info@amrif.eu
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RESCAP
RESCAP is a medication based on the enzyme alkaline phosphatase designed to supplement declining enzyme levels associated with aging and treat age-related diseases.

Research & Development

Amrif is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Jun 8, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$113.8KThis year, Amrif is projected to spend $113.8K on IT, according to Aberdeen.

Active Website Tech Count

5Amrif is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Person Schema.

Total IP

4The intellectual property of Amrif includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Amrif's headquarters? Amrif is located in Wageningen, Gelderland, The Netherlands.Who are Amrif's competitors? Alternatives and possible competitors to Amrif may include AbbVie, Novartis, and  Sanofi.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|